Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Neonatal Perinatal Med ; 9(2): 187-94, 2016 May 19.
Artigo em Inglês | MEDLINE | ID: mdl-27197932

RESUMO

OBJECTIVE: We previously demonstrated a significant reduction in our incidence of chronic lung disease in our NICU using potentially better practices of avoiding delivery room endotracheal intubation and using early nasal CPAP. We sought to demonstrate whether these improvements were sustained and or improved over time. STUDY DESIGN: We conducted a retrospective, cross-sectional analysis of infants 501-1500 grams born at our hospital between 2005 and 2013. Infants born during the 2005-2007, 2008-2010 and 2011-2013 epochs were grouped together, respectively. Descriptive analysis was conducted to determine the number and percent of maternal and neonatal characteristics by year grouping. Chi-squared tests were used to determine whether there were any statistically significant changes in characteristics across year groupings.. Two outcome variables were assessed: a diagnosis of chronic lung disease based on the Vermont Oxford Network definition and being discharged home on supplemental oxygen. RESULTS: There was a statistically significant improvement in the incidence of chronic lung disease in infants below 27 weeks' gestation in the three year period in the 2011-2013 cohort compared with those in the 2005-2007 cohort. We also found a statistically significant improvement in the number of infants discharged on home oxygen with birth weights 751-1000 grams and infants with gestational age less than 27 weeks in the 2011-2013 cohort compared to the 2005-2007 cohort. CONCLUSIONS: We demonstrated sustained improvement in our incidence of CLD between 2005 and 2013. We speculate that a multifaceted strategy of avoiding intubation and excessive oxygen in the delivery room, the early use of CPAP, as well as the use of volume targeted ventilation, when needed, may help significantly reduce the incidence of CLD.


Assuntos
Doença Crônica/terapia , Pressão Positiva Contínua nas Vias Aéreas , Doenças do Prematuro/epidemiologia , Unidades de Terapia Intensiva Neonatal , Pneumopatias/epidemiologia , Estudos Transversais , Feminino , Idade Gestacional , Humanos , Recém-Nascido , Doenças do Prematuro/fisiopatologia , Doenças do Prematuro/terapia , Recém-Nascido de muito Baixo Peso , Intubação Intratraqueal/estatística & dados numéricos , Pneumopatias/fisiopatologia , Pneumopatias/terapia , Masculino , Guias de Prática Clínica como Assunto , Melhoria de Qualidade , Estudos Retrospectivos , Resultado do Tratamento , Estados Unidos
2.
Brain Res ; 314(1): 126-30, 1984 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-6697247

RESUMO

Ablation of one auditory cortex at birth in rats results in the formation of aberrant crossed projections from the intact hemisphere. These aberrant projections extend throughout most of the corticorecipient zone of the contralateral inferior colliculus and can be traced as far rostral as the contralateral medial geniculate nucleus. The aberrant crossed corticothalamic axons arise from layer V pyramidal neurons in the intact auditory cortex.


Assuntos
Córtex Auditivo/lesões , Vias Auditivas/patologia , Corpos Geniculados/patologia , Colículos Superiores/patologia , Animais , Animais Recém-Nascidos , Córtex Auditivo/patologia , Ratos
3.
Biochem Biophys Res Commun ; 114(3): 976-84, 1983 Aug 12.
Artigo em Inglês | MEDLINE | ID: mdl-6688525

RESUMO

Total glycosaminoglycan levels are similar from subcutaneous, ascites and mesenteric forms of the P1798 lymphosarcoma. However, P1798 cells implanted subcutaneously produce a solid tumor rich in hyaluronic acid with lesser amounts of chondroitin 4-/6-sulfates as well as an undersulfated species of chondroitin sulfate, while cells implanted intraperitoneally produce ascites tumors which generate hyaluronic acid, almost exclusively. Mice bearing advanced ascites tumors develop solid mesenteric tumors which exhibit chondroitin 4-/6-sulfates and under-sulfated chondroitin sulfate in addition to hyaluronic acid.


Assuntos
Glicosaminoglicanos/análise , Linfoma não Hodgkin/análise , Sarcoma Experimental/análise , Animais , Ascite/metabolismo , Glucose-6-Fosfato Isomerase/metabolismo , Glicosaminoglicanos/biossíntese , Linfoma não Hodgkin/patologia , Camundongos , Sarcoma Experimental/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...